VA Connecticut Healthcare System
VA Connecticut Healthcare System
Explore linked clinical trials.13 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cannabidiol in Opioid Use Disorder and Chronic Pain | Chemically-Induced Disorders, Chronic Pain, Narcotic-Related Disorders, Neurologic Manifestations, Opioid Use Disorder, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Early phase 1 | 2026-10-05 | NCT04587791 | |
| Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study | Chemically-Induced Disorders, Stress Disorders, Traumatic, acute stress disorder, alcohol-related disorders, post-traumatic stress disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-09-21 | NCT06580444 | |
| Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study | Chemically-Induced Disorders, Stress Disorders, Traumatic, acute stress disorder, alcohol-related disorders, post-traumatic stress disorder, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 | 2026-09-21 | NCT06335407 | |
| Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 2 | Headache Disorders, Secondary, Post-Traumatic Headache, brain disorder, central nervous system disorder, headache disorder, nervous system disorder | Recruiting | Phase 2 | 2026-09-08 | NCT07796074 | |
| PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Early phase 1 | 2026-07-16 | NCT05906511 | |
| Effects of Dronabinol in Opioid Maintained Patients | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Early phase 1 | 2026-07-16 | NCT04025359 | |
| Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Not yet recruiting | Phase 2 | 2026-07-07 | NCT07189585 | |
| Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-07-02 | NCT06058624 | |
| Chiropractic Care for Episodic Migraine | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Not applicable | 2026-06-26 | NCT06229834 | |
| Donepezil and Cognitive Training for Alcohol Use Disorder (AUD) | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-06-23 | NCT05042102 | |
| Substance Misuse and Family Violence Treatment Fathers | Child Abuse; Substance Misuse; Violence, Domestic | Recruiting | Phase 2 | 2026-05-22 | NCT06650267 | |
| The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects | Bipolar and Related Disorders, Stress Disorders, Traumatic, acute stress disorder, bipolar disorder, depressive disorder, major depressive disorder, mood disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-05-06 | NCT05786066 | |
| M2VA Pain Care Pathway | Chemically-Induced Disorders, Narcotic-Related Disorders, Neurologic Manifestations, Opioid Misuse, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Substance Use, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-11-05 | NCT06526143 |